MedTrace Logo

Dietary Lipids, Energy Expenditure and Obesity Biomarkers

NCT02656940 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2016-01-15

No results posted yet for this study

Summary

The purpose of this study is to determine whether the modulation of dietary lipids are effective in the treatment of obesity and comorbidities.

Conditions

Interventions

DIETARY_SUPPLEMENT

Group 1 - diet rich in n-3 and n-6 PUFA

In order to achieve the desired intake of unsaturated FA, the group received individual portions of vegetable oils in the form of sachets, which were consumed for lunch and dinner, besides gelatin capsules, for 60 days.

DIETARY_SUPPLEMENT

Group 2 - diet rich in MUFA

In order to achieve the desired intake of unsaturated FA, the group received individual portions of vegetable oils in the form of sachets, which were consumed for lunch and dinner, besides gelatin capsules, for 60 days.

DIETARY_SUPPLEMENT

Group 3 - Placebo group

Placebo group was instructed to keep their eating habits and consuming placebo for 60 days.

Sponsors & Collaborators

  • Universidade Federal do Rio de Janeiro

    lead OTHER

Principal Investigators

  • Eliane L Rosado, Doctor · UFRJ

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-05-31
Completion
2014-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02656940 on ClinicalTrials.gov